{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:33:30Z","timestamp":1790609610044,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"PRVOUK","award":["P37\/5"],"award-info":[{"award-number":["P37\/5"]}]},{"name":"PRVOUK","award":["P37\/6"],"award-info":[{"award-number":["P37\/6"]}]},{"name":"IGA NT","award":["13457-4-2012"],"award-info":[{"award-number":["13457-4-2012"]}]},{"DOI":"10.13039\/100007162","name":"VEGA","doi-asserted-by":"publisher","award":["1\/0227\/12"],"award-info":[{"award-number":["1\/0227\/12"]}],"id":[{"id":"10.13039\/100007162","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007162","name":"VEGA","doi-asserted-by":"publisher","award":["\/00183\/12"],"award-info":[{"award-number":["\/00183\/12"]}],"id":[{"id":"10.13039\/100007162","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.ijcard.2015.07.103","type":"journal-article","created":{"date-parts":[[2015,8,4]],"date-time":"2015-08-04T02:19:04Z","timestamp":1438654744000},"page":"358-367","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Experimental determination of diagnostic window of cardiac troponins in the development of chronic anthracycline cardiotoxicity and estimation of its predictive value"],"prefix":"10.1016","volume":"201","author":[{"given":"Michaela","family":"Adamcova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Lencova-Popelova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Jirkovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvona","family":"Mazurova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Palicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fedor","family":"Simko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Gersl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Sterba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ijcard.2015.07.103_bb0005","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1053\/j.seminoncol.2013.01.008","article-title":"Strategies to prevent and treat cardiovascular risk in cancer patients","volume":"40","author":"Cardinale","year":"2013","journal-title":"Semin. Oncol."},{"issue":"2","key":"10.1016\/j.ijcard.2015.07.103_bb0010","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/annonc\/mdq609","article-title":"Anthracycline cardiotoxicity in the elderly cancer patient: a SIOG expert position paper","volume":"22","author":"Aapro","year":"2011","journal-title":"Ann. Oncol."},{"issue":"Suppl. 1","key":"10.1016\/j.ijcard.2015.07.103_bb0015","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1517\/14740338.2011.589834","article-title":"Anthracycline cardiotoxicity","volume":"11","author":"Menna","year":"2012","journal-title":"Expert Opin. Drug Saf."},{"issue":"1","key":"10.1016\/j.ijcard.2015.07.103_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/eurjhf\/hfq213","article-title":"Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology","volume":"13","author":"Eschenhagen","year":"2011","journal-title":"Eur. J. Heart Fail."},{"issue":"23","key":"10.1016\/j.ijcard.2015.07.103_bb0025","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1016\/j.jacc.2012.08.969","article-title":"ACCF 2012 expert consensus document on practical clinical considerations in the interpretation of troponin elevations: a report of the American College of Cardiology Foundation task force on Clinical Expert Consensus Documents","volume":"60","author":"Newby","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.ijcard.2015.07.103_bb0030","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1080\/01926230490261302","article-title":"Serum troponins as biomarkers of drug-induced cardiac toxicity","volume":"32","author":"Wallace","year":"2004","journal-title":"Toxicol. Pathol."},{"issue":"1","key":"10.1016\/j.ijcard.2015.07.103_bb0035","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1200\/JCO.2008.17.2627","article-title":"American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants","volume":"27","author":"Hensley","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.ijcard.2015.07.103_bb0040","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1093\/ehjci\/jeu192","article-title":"Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"15","author":"Plana","year":"2014","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"issue":"7","key":"10.1016\/j.ijcard.2015.07.103_bb0045","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1200\/JCO.1999.17.7.2237","article-title":"Correlation between serum levels of cardiac troponin-T and the severity of the chronic cardiomyopathy induced by doxorubicin","volume":"17","author":"Herman","year":"1999","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.ijcard.2015.07.103_bb0050","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1124\/jpet.112.198358","article-title":"Chronic anthracycline cardiotoxicity: molecular and functional analysis with focus on nuclear factor erythroid 2-related factor 2 and mitochondrial biogenesis pathways","volume":"343","author":"Jirkovsky","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.ijcard.2015.07.103_bb0055","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.tox.2013.06.012","article-title":"Early and delayed cardioprotective intervention with dexrazoxane each show different potential for prevention of chronic anthracycline cardiotoxicity in rabbits","volume":"311","author":"Jirkovsky","year":"2013","journal-title":"Toxicology"},{"issue":"5","key":"10.1016\/j.ijcard.2015.07.103_bb0060","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/sj.bjc.6605192","article-title":"Dexrazoxane-afforded protection against chronic anthracycline cardiotoxicity in vivo: effective rescue of cardiomyocytes from apoptotic cell death","volume":"101","author":"Popelova","year":"2009","journal-title":"Br. J. Cancer"},{"issue":"1\u20132","key":"10.1016\/j.ijcard.2015.07.103_bb0065","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0009-8981(03)00013-5","article-title":"Evaluation of cardiac troponin I and T levels as markers of myocardial damage in doxorubicin-induced cardiomyopathy rats, and their relationship with echocardiographic and histological findings","volume":"329","author":"Bertinchant","year":"2003","journal-title":"Clin. Chim. Acta"},{"issue":"4","key":"10.1016\/j.ijcard.2015.07.103_bb0070","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1177\/0192623311406931","article-title":"Baseline serum cardiac troponin I concentrations in Sprague\u2013Dawley, spontaneous hypertensive, Wistar, Wistar\u2013Kyoto, and Fisher rats as determined with an ultrasensitive immunoassay","volume":"39","author":"Herman","year":"2011","journal-title":"Toxicol. Pathol."},{"issue":"5","key":"10.1016\/j.ijcard.2015.07.103_bb0075","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s004320050273","article-title":"Cardiac troponin T as a marker of myocardial damage caused by antineoplastic drugs in rabbits","volume":"125","author":"Adamcova","year":"1999","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"1\u20133","key":"10.1016\/j.ijcard.2015.07.103_bb0080","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.tox.2007.05.016","article-title":"In vitro and in vivo examination of cardiac troponins as biochemical markers of drug-induced cardiotoxicity","volume":"237","author":"Adamcova","year":"2007","journal-title":"Toxicology"},{"issue":"8","key":"10.1016\/j.ijcard.2015.07.103_bb0085","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1177\/0192623313482056","article-title":"Comparison of cardiac troponin I and T, including the evaluation of an ultrasensitive assay, as indicators of doxorubicin-induced cardiotoxicity","volume":"41","author":"Reagan","year":"2013","journal-title":"Toxicol. Pathol."},{"issue":"5","key":"10.1016\/j.ijcard.2015.07.103_bb0090","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1309\/AJCPB66LRIIVMQDR","article-title":"Biochemical markers for prediction of chemotherapy-induced cardiotoxicity: systematic review of the literature and recommendations for use","volume":"130","author":"Dolci","year":"2008","journal-title":"Am. J. Clin. Pathol."},{"issue":"3","key":"10.1016\/j.ijcard.2015.07.103_bb0095","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1161\/01.CIR.83.3.902","article-title":"Diagnostic efficiency of troponin T measurements in acute myocardial infarction","volume":"83","author":"Katus","year":"1991","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.ijcard.2015.07.103_bb0100","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/clinchem\/37.6.845","article-title":"Cardiac troponin T in diagnosis of acute myocardial infarction","volume":"37","author":"Mair","year":"1991","journal-title":"Clin. Chem."},{"issue":"6 Pt 1","key":"10.1016\/j.ijcard.2015.07.103_bb0105","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1093\/clinchem\/44.6.1198","article-title":"Characterization of cardiac troponin subunit release into serum after acute myocardial infarction and comparison of assays for troponin T and I. American Association for Clinical Chemistry Subcommittee on cTnI Standardization","volume":"44","author":"Wu","year":"1998","journal-title":"Clin. Chem."},{"issue":"2\u20133","key":"10.1016\/j.ijcard.2015.07.103_bb0110","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0940-2993(11)80297-6","article-title":"Diagnostic efficiency of troponin T measurements in rats with experimental myocardial cell damage","volume":"47","author":"Bleuel","year":"1995","journal-title":"Exp. Toxicol. Pathol."},{"issue":"6","key":"10.1016\/j.ijcard.2015.07.103_bb0115","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0940-2993(97)80138-8","article-title":"Comparison of cardiac Troponin T and cardiac Troponin I concentrations in peripheral blood during orciprenaline induced tachycardia in rats","volume":"49","author":"Bertsch","year":"1997","journal-title":"Exp. Toxicol. Pathol."},{"issue":"8","key":"10.1016\/j.ijcard.2015.07.103_bb0120","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1161\/01.CIR.96.8.2641","article-title":"Predictive value of cardiac troponin T in pediatric patients at risk for myocardial injury","volume":"96","author":"Lipshultz","year":"1997","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.ijcard.2015.07.103_bb0125","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1177\/0192623309343777","article-title":"Longitudinal studies of cardiac troponin-I concentrations in serum from male Sprague Dawley rats: baseline reference ranges and effects of handling and placebo dosing on biological variability","volume":"37","author":"Schultze","year":"2009","journal-title":"Toxicol. Pathol."},{"issue":"5","key":"10.1016\/j.ijcard.2015.07.103_bb0130","first-page":"798","article-title":"cTnT can be a useful marker for early detection of anthracycline cardiotoxicity","volume":"16","author":"Kilickap","year":"2005","journal-title":"Exp. Toxicol. Pathol."},{"issue":"10","key":"10.1016\/j.ijcard.2015.07.103_bb0135","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1159\/000151687","article-title":"Cardiac troponin I seems to be superior to cardiac troponin T in the early detection of cardiac injury associated with anthracycline treatment","volume":"31","author":"Horacek","year":"2008","journal-title":"Onkologie"},{"issue":"4","key":"10.1016\/j.ijcard.2015.07.103_bb0140","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1470-2045(09)70042-7","article-title":"Cardiovascular toxicity caused by cancer treatment: strategies for early detection","volume":"10","author":"Altena","year":"2009","journal-title":"Lancet Oncol."},{"issue":"2","key":"10.1016\/j.ijcard.2015.07.103_bb0145","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.pcad.2010.04.002","article-title":"Role of biomarkers in chemotherapy-induced cardiotoxicity","volume":"53","author":"Cardinale","year":"2010","journal-title":"Prog. Cardiovasc. Dis."},{"issue":"3","key":"10.1016\/j.ijcard.2015.07.103_bb0150","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1177\/096032719901800304","article-title":"IGF-I in experimental daunorubicin-induced cardiomyopathy in rabbits","volume":"18","author":"Gersl","year":"1999","journal-title":"Hum. Exp. Toxicol."},{"issue":"1","key":"10.1016\/j.ijcard.2015.07.103_bb0155","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/jvim.12530","article-title":"Cardiac troponin I as compared to troponin T for the detection of myocardial damage in horses","volume":"29","author":"Van Der Vekens","year":"2015","journal-title":"J. Vet. Intern. Med."},{"issue":"1","key":"10.1016\/j.ijcard.2015.07.103_bb0160","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/toxsci\/kfu057","article-title":"An integrated characterization of serological, pathological, and functional events in doxorubicin-induced cardiotoxicity","volume":"140","author":"Cove-Smith","year":"2014","journal-title":"Toxicol. Sci."},{"issue":"2","key":"10.1016\/j.ijcard.2015.07.103_bb0165","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0735-1097(00)00748-8","article-title":"Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy","volume":"36","author":"Cardinale","year":"2000","journal-title":"J. Am. Coll. Cardiol."},{"issue":"8","key":"10.1016\/j.ijcard.2015.07.103_bb0170","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1373\/clinchem.2013.217943","article-title":"Revision of the troponin T release mechanism from damaged human myocardium","volume":"60","author":"Starnberg","year":"2014","journal-title":"Clin. Chem."},{"issue":"1","key":"10.1016\/j.ijcard.2015.07.103_bb0175","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ahj.2011.04.005","volume":"162","author":"Newby","year":"2011","journal-title":"Am. Heart J."},{"issue":"13","key":"10.1016\/j.ijcard.2015.07.103_bb0180","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1134\/S0006297913130063","article-title":"Human cardiac troponin complex. Structure and functions","volume":"78","author":"Katrukha","year":"2013","journal-title":"Biochem. Biokhimiia."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527315302242?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527315302242?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,6]],"date-time":"2020-09-06T16:59:26Z","timestamp":1599411566000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527315302242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":36,"alternative-id":["S0167527315302242"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2015.07.103","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Experimental determination of diagnostic window of cardiac troponins in the development of chronic anthracycline cardiotoxicity and estimation of its predictive value","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2015.07.103","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}